Adam J. Gehring
Adam J. Gehring
Toronto Centre for Liver Disease
Verified email at - Homepage
Cited by
Cited by
Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells
M Haniffa, A Shin, V Bigley, N McGovern, P Teo, P See, PS Wasan, ...
Immunity 37 (1), 60, 2012
The immune response during hepatitis B virus infection
A Bertoletti, AJ Gehring
Journal of General Virology 87 (6), 1439-1449, 2006
Modulation of the CD8+-T-Cell Response by CD4+ CD25+ Regulatory T Cells in Patients with Hepatitis B Virus Infection
O Franzese, PTF Kennedy, AJ Gehring, J Gotto, R Williams, MK Maini, ...
Journal of virology 79 (6), 3322-3328, 2005
IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells
XZ Tang, J Jo, AT Tan, E Sandalova, A Chia, KC Tan, KH Lee, AJ Gehring, ...
The Journal of Immunology 190 (7), 3142-3152, 2013
Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing
AJ Gehring, KM Dobos, JT Belisle, CV Harding, WH Boom
The Journal of immunology 173 (4), 2660-2668, 2004
A global scientific strategy to cure hepatitis B
PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ...
The Lancet Gastroenterology & Hepatology 4 (7), 545-558, 2019
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ...
Journal of hepatology 52 (3), 370-379, 2010
Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection
AR Lopes, P Kellam, A Das, C Dunn, A Kwan, J Turner, D Peppa, ...
The Journal of clinical investigation 118 (5), 1835-1845, 2008
Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function
ND Pecora, AJ Gehring, DH Canaday, WH Boom, CV Harding
The Journal of immunology 177 (1), 422-429, 2006
Human immunity to M. tuberculosis: T cell subsets and antigen processing
WH Boom, DH Canaday, SA Fulton, AJ Gehring, RE Rojas, M Torres
Tuberculosis 83 (1-3), 98-106, 2003
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver
J Jo, AT Tan, JE Ussher, E Sandalova, XZ Tang, A Tan-Garcia, N To, ...
PLoS pathogens 10 (6), e1004210, 2014
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines
AJ Gehring, SA Xue, ZZ Ho, D Teoh, C Ruedl, A Chia, S Koh, SG Lim, ...
Journal of hepatology 55 (1), 103-110, 2011
The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like …
AJ Gehring, RE Rojas, DH Canaday, DL Lakey, CV Harding, WH Boom
Infection and immunity 71 (8), 4487-4497, 2003
Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma
AJ Gehring, ZZ Ho, AT Tan, MO Aung, KH Lee, KC Tan, SG Lim, ...
Gastroenterology 137 (2), 682-690, 2009
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
W Qasim, M Brunetto, AJ Gehring, SA Xue, A Schurich, A Khakpoor, ...
Journal of hepatology 62 (2), 486-491, 2015
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B
AT Tan, S Koh, W Goh, HY Zhe, AJ Gehring, SG Lim, A Bertoletti
Journal of hepatology 52 (3), 330-339, 2010
The role of innate immunity in the immunopathology and treatment of HBV infection
MK Maini, AJ Gehring
Journal of hepatology 64 (1), S60-S70, 2016
Trained immunity in newborn infants of HBV-infected mothers
M Hong, E Sandalova, D Low, AJ Gehring, S Fieni, B Amadei, S Urbani, ...
Nature communications 6 (1), 6588, 2015
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
JJ Feld, C Kandel, MJ Biondi, RA Kozak, MA Zahoor, C Lemieux, ...
The Lancet Respiratory Medicine 9 (5), 498-510, 2021
Targeting innate and adaptive immune responses to cure chronic HBV infection
AJ Gehring, U Protzer
Gastroenterology 156 (2), 325-337, 2019
The system can't perform the operation now. Try again later.
Articles 1–20